Similar Search Results

Relevance of indirect comparisons in the German early benefit assessment and in comparison to HTA processes in England, France and Scotland

Lebioda, Andrea; Gasche, David; Dippel, Franz-Werner; … - In: Health economics review 4 (2014) 31, pp. 1-14

Early benefit assessment in Germany under the legislative framework of AMNOG (Arzneimittelmarktneuordnungsgesetz … assessments (HTA), like France, England and Scotland. Our evaluation shows that a comparison of the different HTA regarding …

Persistent link: https://www.econbiz.de/10010526947

Requirements for benefit assessment in Germany and England : overview and comparison

Ivandic, Victor - In: Health economics review 4 (2014) 12, pp. 1-14

Federal Joint Committee/Institute for Quality and Efficiency in Health Care (G-BA/IQWiG; Germany) and the National Institute …

Persistent link: https://www.econbiz.de/10010528485

Regional differences in health care of patients with inflammatory bowel disease in Germany

Lange, Ansgar; Prenzler, Anne; Bachmann, Frank Oliver; … - In: Health economics review 5 (2015) 29, pp. 1-11

healthcare of IBD patients in Germany?" Methods: We combined a claims dataset from a German health insurance fund with population …

Persistent link: https://www.econbiz.de/10011472028

Leveraging EUnetHTA's conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer’s point of view

Giuliani, Giovanni; Chassagnol, Frederic; Traub, David; … - In: Health economics review 8 (2018) 24, pp. 1-11

. We reviewed recent appraisals of a pharmaceutical manufacturer in three major European markets (France; Italy; Germany …. Important drivers related to the other three clinical domains included the target patient population (subgroups, Germany), the … current management of the condition (unmet need, Italy), the regulatory status (Orphan Designation, Germany), as well as …

Persistent link: https://www.econbiz.de/10011942836

A comparison of the cost-effectiveness of treatment of prolonged acute convulsive epileptic seizures in children across Europe

Lee, Dawn C.; Gladwell, Daniel; Hatswell, Anthony J.; … - In: Health economics review 4 (2014) 6, pp. 1-15

In the majority of children and adolescents with epilepsy, optimal drug therapy adequately controls their condition. However, among the remaining patients who are still uncontrolled despite mono-, bi- or tri-therapy with chronic anti-epileptic treatment, a rescue medication is required. In...

Persistent link: https://www.econbiz.de/10010528456

How much do government and households spend on an episode of hospitalisation in India? : a comparison for public and private hospitals in Chhattisgarh state

Garg, Samir; Tripathi, Narayan; Ranjan, Alok; Bebarta, … - In: Health economics review 12 (2022) 1, pp. 1-15

have not taken into account the healthcare spending by government. Methods: For a valid comparison between public and for …

Persistent link: https://www.econbiz.de/10013198813

No theory : an explanation of the lack of consistency in cross-country health care comparisons using non-parametric estimators

Gearhart, Richard - In: Health economics review 6 (2016) 40, pp. 1-12

Since 2000 several papers have examined the efficiency of healthcare delivery systems worldwide. These papers have extended the literature using drastically different input and output combinations from one another, with little theoretical or empirical support backing these specifications. Issues...

Persistent link: https://www.econbiz.de/10011586629

A comparative profitability analysis of transcatheter versus surgical aortic valve replacement in a high-volume French hospital

Huchet, François; Chan-Peng, Jacques; d’Acremont, Fanny - In: Health economics review 9 (2019) 6, pp. 1-7

previously demonstrated that the TAVR procedure generated profits despite elevated costs, but comparison with surgery has not …

Persistent link: https://www.econbiz.de/10011982826

Comparison of the cost of illness of primary liver cancer between Japan and Taiwan

Wu, Yinghui; Matsumoto, Kunichika; Chen, Ya-Mei; Tung, … - In: Health economics review 10 (2020) 38, pp. 1-7

Background: Primary liver cancer (PLC) is the fifth and second leading cause of death in Japan and Taiwan, respectively. The aim of this study was to compare the economic burden of PLC between the two countries using the cost of illness (COI) method and identify the key factors causing the...

Persistent link: https://www.econbiz.de/10012390966

The healthcare inequality among middle-aged and older adults in China : a comparative analysis between the full samples and the homogeneous population

Fu, Liping; Fang, Ya'nan; Dong, Yongqing - In: Health economics review 12 (2022) 1, pp. 1-17

Background: In the Chinese population, the middle-aged and older adults are the two main segments that utilize a large portion of healthcare. With the fast growth of the two segments, the demands of healthcare services increases significantly. The issue related to inequality in utilization of...

Persistent link: https://www.econbiz.de/10013329471